A comprehensive preventative screening test combining two advanced technologies: liquid-based cytology (LBC) and high-risk HPV DNA detection using polymerase chain reaction (PCR). Both are performed on a single liquid sample. It is considered the modern gold standard for early cervical cancer screening, providing simultaneous assessment of current cellular changes and the presence of the primary causative agent.